Cigna

Investment management for Cigna's general account sits with Cigna Investment Management, a wholly owned subsidiary that reports up through the CFO — currently Ann Dennison — to the CEO and board. The firm publicly identifies its senior investment team in annual filings but does not disclose a single named CIO externally. Succession planning has been explicit: Brian Evanko, the current President and COO and former CFO, becomes CEO in July 2026.

The general account is structurally driven by health insurance liability duration — often 15 to 30-year medical and disability claim tails — which pushes the portfolio into longer-duration fixed-income assets than a typical corporate cash pool. Cigna Investment Management directly originates commercial mortgage loans and private-placement debt, allowing the firm to earn an illiquidity premium while holding assets to maturity, a posture unavailable to mark-to-market asset managers.

No. Cigna is a publicly traded health insurance and pharmacy benefit management company that operates an internal asset management division solely for its own general account. The firm does not manage third-party capital, nor does it function as a multi-family office despite the scale of its investment operations.

The Cigna Group Foundation is a separate legal entity funded by Cigna's corporate treasury, distinct from the general account insurance reserves. It focuses on community health grants and operates independently of Cigna Investment Management's portfolio assets, though both report under the same corporate umbrella.

Cigna owns its headquarters campus at 900 Cottage Grove Road in Bloomfield, Connecticut, and operates Cigna Realty Investors, which holds a mixed-use portfolio across the United States. The firm also maintains a corporate art collection across its Philadelphia and Bloomfield offices, publicly documented in Cigna's own materials.

Brian Evanko, the firm's President and COO and a former CFO, will become CEO of The Cigna Group in July 2026, with David Cordani transitioning to Executive Chairman. The announcement came via official firm communications in January 2026, making this one of the few fully telegraphed CEO successions in the S&P 500 healthcare sector.

CIM directly underwrites fixed-rate commercial mortgage loans across primary and secondary US markets, holding positions in office, multifamily, and industrial properties. These loans sit in the general account and are held to maturity, aligned with the long-dated claim liabilities they fund — a structure that gives CIM a pricing advantage over banks and CMBS-dependent lenders in the 5- to 15-year fixed-rate space.